Conference
Impact of a change of body mass index (BMI) on outcome following adjuvant endocrine therapy, chemotherapy, or trastuzumab for breast cancer.
Authors
Yerushalmi R; Dong B; Chapman JW; Goss PE; Pollak MN; Burnell MJ; Bramwell VH; Levine MN; Pritchard KI; Whelan TJ
Volume
29
Pagination
pp. 513-513
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2011
DOI
10.1200/jco.2011.29.15_suppl.513
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X